Antitrust

A new therapy for a rare brain cancer is one step closer to patients after the FDA accepted tirabrutinib for accelerated review, offering hope where few options exist.

As firms face a data deluge and new rules, Normative's new service outsources the heavy lifting of carbon accounting for overstretched teams.

German giant Hapag-Lloyd's $4.2B cash buyout of ZIM creates a new shipping powerhouse and a unique Israeli carrier to secure national interests.

Top policymakers, including Dr. Agustín Carstens and FATF President Luis Urrutia Corral, will convene in Mérida to address critical cross-border tax issues.

A Spanish court has warned Ryanair officials of criminal liability for defying court orders, a major escalation in its bitter feud with the travel platform.

With its IPO complete, Cambridge Acquisition Corp. enters a disciplined SPAC market with a clear focus on wellness, hemp, and psychedelic tech targets.

A gay executive's lawsuit claims Wells Fargo denied him a promotion, told him to be 'on the down low,' and caused a permanent mental health crisis.

In a strategic pivot, Fresh Del Monte gets court approval to buy packaged food assets from its bankrupt namesake, aiming to unify the iconic brand.

With a new focus on eye disease and fresh funding, Surrozen will present its novel Wnt-based pipeline to investors. What's at stake for the future of sight?

Jawad Rathore and Vincenzo Petrozza sentenced to 5 years for a massive fraud that cost nearly 800 investors their savings and sparked major reforms.

Winners Inc. launches MeVu, a 'Tinder for sports trading,' but can it navigate a complex legal landscape and turn the company's fortunes around?

Brad Karp's 18-year reign ends abruptly after his ties to Jeffrey Epstein create a 'distraction,' paving the way for dealmaker Scott Barshay to lead.

Shareholders to vote on a US$3.65 per share all-cash deal, a significant premium that will take the growing respiratory care provider private.

SiTime acquires Renesas' timing business in a bold move to dominate the AI and datacenter market and accelerate its path to $1 billion in revenue.

As X4 Pharmaceuticals preps for a key investor summit, all eyes are on its pivotal trial for chronic neutropenia and the commercial fate of XOLREMDI®.

S. Penny Windle Kline, a top litigator, joins SEDA's board in a move to dominate the complex financial litigation and expert witness market.

Cadent's new 100% direct CTV inventory, validated by Jounce Media, aims to eliminate ad waste and sets a new benchmark for transparency in the industry.

A tech startup’s AI has published more new scent patents than all major fragrance houses combined, signaling a massive disruption for the perfume industry.

Amid user skepticism, broker review giant WikiFX vows to separate ratings from revenue, promising a purely data-driven evaluation model for traders.

The acquisition of Italian specialist SPIN360 signals a major shift toward verifiable sustainability and data-driven compliance in the high-fashion industry.